Title : Insulin therapy in type 2 diabetes: what is the evidence?

Pub. Date : 2009 May

PMID : 19175375






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Continuing metformin and/or sulphonylurea after start of therapy with basal long-acting insulin results in better glycaemic control with less insulin requirements, less weight gain and less hypoglycaemic events. Sulfonylurea Compounds insulin Homo sapiens
2 Continuing metformin and/or sulphonylurea after start of therapy with basal long-acting insulin results in better glycaemic control with less insulin requirements, less weight gain and less hypoglycaemic events. Sulfonylurea Compounds insulin Homo sapiens